Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Folate-dependent enzymes are a group of enzymes that utilize folate derivatives as cofactors to catalyze key reactions in the synthesis of nucleotides, which are essential for DNA and RNA production. These enzymes play critical roles in both purine and pyrimidine nucleotide biosynthesis pathways, supporting cell proliferation, DNA repair, and genomic stability. Key enzymes include Glycinamide Ribonucleotide Formyltransferase (GARFT), Aminoimidazole Carboxamide Ribonucleotide Formyltransferase (AICARFT), Thymidylate Synthase (TYMS), Dihydrofolate Reductase (DHFR), and Serine Hydroxymethyltransferase (SHMT). These enzymes are important therapeutic targets, and antifolate drugs are used in cancer therapy.
Enzyme inhibition
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Folate-Dependent Enzymes Involved in Nucleotide Synthesis (Folate-Dependent Nucleotide Enzymes).